Can Letrozole Cause Dizziness and How to Manage It

Dizziness is a recognized side effect of letrozole, reported more often with this drug than with some alternative hormone-related medications. In a large randomized trial comparing letrozole with clomiphene in women with polycystic ovary syndrome, letrozole was specifically associated with higher rates of both dizziness and fatigue. The symptom is not universal, but it is common enough that researchers and prescribing guides consistently list it among expected adverse effects. Understanding why it happens and what you can do about it requires a look at how deeply letrozole reshapes your hormonal environment.

How Often Dizziness Shows Up

Letrozole belongs to a class of drugs called aromatase inhibitors, which work by shutting down the body’s production of estrogen. In clinical trials across its various uses, dizziness appears on the list of commonly reported side effects, though it tends to be less headline-grabbing than joint pain or hot flashes. In the landmark trial published in the New England Journal of Medicine that compared letrozole to clomiphene for infertility treatment, researchers noted that letrozole was linked to higher incidences of fatigue and dizziness, while clomiphene caused more hot flashes.¹ That particular trial enrolled over 750 women, so this was not a fluke finding from a handful of patients.

For women taking letrozole in the context of breast cancer treatment, dizziness also appears in adverse event reporting, though the precise rate varies across trials depending on the patient population, duration of use, and dosage. It is typically classified as a mild to moderate side effect rather than a severe one, but “mild” on a clinical grading scale can still be disruptive when it interferes with driving, exercise, or daily tasks. Side effects like these are, in fact, one of the main reasons women stop taking their endocrine therapy early.²

Why Letrozole Causes Dizziness

The most likely explanation connects directly to what letrozole does best. Letrozole is the most potent of the third-generation aromatase inhibitors, producing near-complete suppression of estrogen in peripheral tissues. It achieves greater estrogen suppression than anastrozole, exemestane, and older drugs in the same family.³ That potency is what makes it effective against estrogen-receptor-positive breast cancer and useful in fertility treatment, but it also means the body experiences a dramatic drop in circulating estrogen, and estrogen does more than regulate reproduction.

Estrogen receptors exist throughout the nervous system, including in areas responsible for balance and spatial orientation. The vestibular system, which is housed in your inner ear and tells your brain whether you are upright, tilting, or moving, is influenced by hormonal status. Research into menopause and vertigo has found that the decline in estrogen levels during menopause is linked to increased susceptibility to vestibular disturbances.⁴ Letrozole essentially mimics and intensifies this aspect of menopause by driving estrogen levels even lower than what natural menopause produces.

One study focusing specifically on postmenopausal women concluded that estradiol deficiency is a risk factor for benign paroxysmal positional vertigo, the most common type of vertigo where brief spinning episodes are triggered by changes in head position.⁵ If low estrogen alone can trigger balance problems, then a drug designed to push estrogen to near-zero levels could plausibly amplify that risk. This is the biological thread that ties letrozole use to dizziness, lightheadedness, and in some cases true vertigo with a sensation of the room spinning.

The Vestibular Connection Goes Deeper Than Menopause

It is worth noting that women in general are overrepresented in the incidence of many vestibular disorders, and this pattern extends well beyond the menopausal years. Research into sex differences in vestibular function has found that the higher incidence of balance problems in women persists long after menopause, which suggests that hormonal differences may play a role but are not the entire story.⁶ There may be structural differences in the vestibular system between men and women, or differences in how the brain processes balance signals, that make women more vulnerable to dizziness when their hormonal landscape shifts.

What this means for someone on letrozole is that you may have a baseline susceptibility to vestibular disturbance that the drug magnifies. If you already experienced occasional dizziness before starting letrozole, or if you had balance issues during perimenopause, the drug could make those episodes more frequent or more intense. The dizziness is not all in your head in the dismissive sense, but it is, quite literally, in part a product of your inner ear and brain responding to a hormonal environment they were not designed for.

Other Factors That Can Make It Worse

Letrozole’s estrogen suppression is the primary driver, but several other factors can pile on and make dizziness more of a problem than it needs to be.

• Dehydration: Aromatase inhibitors can increase sweating in some women, especially those also experiencing hot flashes. Not replacing that fluid adequately drops blood volume and blood pressure, which makes lightheadedness on standing far more likely.
• Blood pressure changes: If you are also taking blood pressure medication or a diuretic, the combined effect with letrozole’s own influence on fluid balance can produce postural drops in blood pressure, where standing up quickly leaves you feeling faint.
• Fatigue: The same NEJM trial that linked letrozole to dizziness also noted higher rates of fatigue. Chronic tiredness on its own can worsen perceived dizziness and impair the brain’s ability to compensate for subtle vestibular signals.
• Anemia: Some women undergoing cancer treatment may have low hemoglobin from chemotherapy or other causes. Anemia compounds lightheadedness because less oxygen reaches the brain.
• Anxiety and sleep disruption: Both are common in women on endocrine therapy for breast cancer. Poor sleep alters vestibular processing, and anxiety can amplify the perception of dizziness into something more alarming than it would otherwise feel.

Addressing these contributing factors can sometimes reduce dizziness even when the letrozole itself stays the same. It is worth a systematic check of each one with your prescriber before assuming the drug is entirely at fault.

Practical Ways to Manage Letrozole-Related Dizziness

There is no single fix, but a combination of strategies helps most people keep dizziness manageable enough to stay on the medication.

Stay well hydrated, especially in warm weather or if you are having night sweats. Aim for consistent fluid intake throughout the day rather than trying to catch up all at once. If you notice dizziness is worst in the morning, a glass of water before you get out of bed can help.

Move slowly when changing positions. The classic advice to “get up in stages” is particularly relevant here: sit on the edge of the bed for 30 seconds before standing, hold onto something stable, and wait for any lightheadedness to pass before walking. This is especially important in the middle of the night when you are groggy and your blood pressure is naturally at its lowest.

Timing the dose matters for some people. If your dizziness peaks a few hours after taking letrozole, switching from a morning dose to a bedtime dose (or vice versa) can shift the worst of the effect to a time when it bothers you less. This is a conversation to have with your doctor, but it is a simple adjustment that sometimes makes a real difference.

Vestibular rehabilitation exercises, which are guided balance and gaze-stabilization exercises typically overseen by a physical therapist, can help the brain recalibrate its balance processing. These are the same exercises used for people with vertigo from other causes, and they work by training the brain to rely on alternative sensory cues when the vestibular system is not performing at its best. Even simple habits like standing on one foot while brushing your teeth can gradually improve balance confidence.

Caffeine and alcohol both affect hydration and blood vessel tone, and both can independently worsen dizziness. Cutting back on either during the early weeks of letrozole treatment, when side effects tend to be most noticeable, gives you a cleaner picture of what the drug itself is doing.

When to Escalate the Conversation With Your Doctor

Mild, occasional lightheadedness that responds to hydration and positional awareness is annoying but generally manageable. However, certain patterns warrant a more urgent discussion with your prescriber.

If dizziness is severe enough that you are falling or nearly falling, that is a safety issue that needs prompt attention, especially since letrozole can also reduce bone density over time, making fractures more consequential. True spinning vertigo, where the room appears to rotate for seconds or minutes at a time, is different from general lightheadedness and may indicate a specific vestibular condition like benign paroxysmal positional vertigo, which has its own targeted treatments. Dizziness accompanied by hearing changes, ringing in the ears, or persistent nausea also merits investigation beyond the assumption that letrozole is the sole cause.

If the dizziness is bad enough that you are considering stopping letrozole on your own, it is important to talk to your oncologist or prescriber first. Serious side effects are sometimes resolved by switching to a different aromatase inhibitor or to a different class of endocrine therapy altogether.² Since letrozole is more potent than some alternatives, switching to a less aggressive estrogen suppressor could ease the dizziness while still providing meaningful benefit. The trade-offs depend on your specific cancer type, stage, and risk profile, so this is a decision that requires your doctor’s input rather than an independent judgment call.

A Warning About “Natural” Remedies for Dizziness and Hormonal Symptoms

When you are dealing with symptoms caused by low estrogen, it is natural to think about supplements that might restore some of that estrogen activity. Products marketed as menopausal support supplements often contain phytoestrogens, plant-derived compounds that can mimic estrogen in the body. This is precisely the problem if you are taking letrozole for breast cancer.

Laboratory research has shown that phytoestrogens found in common menopausal supplements, including genistein and 8-prenylnaringenin, can activate estrogen receptors and stimulate the growth of estrogen-receptor-positive breast cancer cells. In experimental models, these compounds overcame the anti-cancer effects of letrozole at concentrations that reflect realistic supplement use.⁷ That is a laboratory finding rather than a clinical trial in humans, but the implication is serious enough that researchers have recommended avoiding menopausal supplements during breast cancer treatment until their safety can be better established.

This means that the most intuitive solution, taking something to counteract low-estrogen symptoms, is potentially the most dangerous one if you are on letrozole for cancer. The same caution applies to soy isoflavone supplements and high-dose soy products, though the data on dietary soy in normal food quantities is less alarming. If you are taking letrozole for fertility rather than cancer, the stakes are different and the phytoestrogen concern is less relevant, but it is still worth mentioning to your doctor before adding supplements.

Does Dizziness Improve Over Time?

Many side effects of aromatase inhibitors follow a pattern where they are worst in the first few weeks to months of treatment and then gradually ease as the body adjusts to a lower-estrogen state. Dizziness often follows this trajectory. The vestibular system has some ability to compensate for changes in its hormonal environment, and the brain is remarkably adaptable when it comes to recalibrating balance over time. If your dizziness is mild, there is a reasonable chance it will become less noticeable after the initial adjustment period.

That said, some women experience persistent dizziness throughout their course of treatment, which for adjuvant breast cancer therapy can mean five or even ten years. In those cases, the management strategies above become a long-term practice rather than a temporary bridge. Vestibular rehabilitation is especially valuable for chronic symptoms because the training effect builds over months and can produce lasting improvements in stability and confidence.

For women taking letrozole in short courses for fertility treatment, the dizziness is typically limited to the days you are actively taking the medication and resolves quickly once the course is finished. The drug’s half-life is about two days, so its effects do not linger for weeks after you stop.

Dizziness Versus Vertigo Versus Lightheadedness

When you tell your doctor you feel “dizzy,” it helps to be specific, because the word covers at least three distinct experiences that point to different causes.

Lightheadedness is the feeling that you might faint. It often happens when you stand up quickly and tends to pass within seconds. This is usually a blood pressure or hydration issue and is the most straightforward type to manage.

Vertigo is the sensation that you or the room is spinning. It can last seconds to minutes and is often triggered by specific head movements. This suggests involvement of the vestibular system in the inner ear and may be related to the estrogen-vestibular connection described earlier. Vertigo has specific treatments, including repositioning maneuvers performed by a clinician, that work well when the cause is identified.

Disequilibrium is a broader sense of unsteadiness or feeling “off” without spinning or faintness. It is harder to pin down and can stem from a combination of vestibular, neurological, and muscular factors. This type of dizziness is the most likely to be chronic and the most responsive to vestibular rehabilitation exercises.

Keeping a brief diary of your episodes, noting when they happen, how long they last, what triggers them, and which of these three categories best describes the sensation, gives your doctor much more useful information than simply reporting “I’m dizzy.” It can mean the difference between generic reassurance and a targeted intervention that actually helps.